Walvax Biotechnology Co., Ltd. (300142) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Walvax Biotechnology Co., Ltd.

Why is Walvax Biotechnology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -5.90% and Operating profit at -32.17% over the last 5 years

Positive results in Mar 26

ROCE(HY) Highest at 3.39%
INVENTORY TURNOVER RATIO(HY) Highest at 1.14 times
PRE-TAX PROFIT(Q) Highest at CNY 148.23 MM

With ROE of 3.40%, it has a attractive valuation with a 2.36 Price to Book Value

Over the past year, while the stock has generated a return of 17.02%, its profits have risen by 117.3% ; the PEG ratio of the company is 0.6
At the current price, the company has a high dividend yield of 0.3

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Walvax Biotechnology Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Walvax Biotechnology Co., Ltd.

17.91%

0.16

45.19%

China Shanghai Composite

3.23%

1.20

14.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-5.90%

EBIT Growth (5y)

-32.17%

EBIT to Interest (avg)

79.14

Debt to EBITDA (avg)

0.18

Net Debt to Equity (avg)

-0.32

Sales to Capital Employed (avg)

0.30

Tax Ratio

16.27%

Dividend Payout Ratio

139.51%

Pledged Shares

Institutional Holding

ROCE (avg)

9.50%

ROE (avg)

9.19%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.52

EV to EBIT

113.54

EV to EBITDA

40.22

EV to Capital Employed

2.44

EV to Sales

7.95

PEG Ratio

0.63

Dividend Yield

1.34%

ROCE (Latest)

2.14%

ROE (Latest)

3.40%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

NET PROFIT(HY)

At CNY 110.78 MM has Grown at 277.28%

ROCE(HY)

Highest at 2.29%

-39What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 551.63 MM

INTEREST COVERAGE RATIO(Q)

Lowest at 746.12

CASH AND EQV(HY)

Lowest at CNY 2,159.35 MM

DEBT-EQUITY RATIO (HY)

Highest at 1.04 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.89 times

NET SALES(Q)

Lowest at CNY 390.37 MM

INTEREST(Q)

Highest at CNY 9.61 MM

OPERATING PROFIT(Q)

Lowest at CNY 71.69 MM

PRE-TAX PROFIT(Q)

Lowest at CNY -16.73 MM

NET PROFIT(Q)

Lowest at CNY -16.81 MM

EPS(Q)

Lowest at CNY -0.04

Here's what is not working for Walvax Biotechnology Co., Ltd.

Net Sales

At CNY 390.37 MM has Fallen at -43.58%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY -16.73 MM has Fallen at -160.02%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -16.81 MM has Fallen at -141.14%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest

At CNY 9.61 MM has Grown at 36.16%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 746.12

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Cash Flow

Lowest at CNY 551.63 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

Lowest at CNY 390.37 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Interest

Highest at CNY 9.61 MM

in the last five periods and Increased by 36.16% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit

Lowest at CNY 71.69 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Pre-Tax Profit

Lowest at CNY -16.73 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY -16.81 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY -0.04

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Cash and Eqv

Lowest at CNY 2,159.35 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at 1.04 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 0.89 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Footer loading